{"id":25796,"date":"2023-05-24T10:17:52","date_gmt":"2023-05-24T14:17:52","guid":{"rendered":"https:\/\/genomequebec.com\/financed-project\/inflammatory-bowel-diseases-genomic-medicine-consortium-igenomed\/"},"modified":"2023-05-24T10:27:24","modified_gmt":"2023-05-24T14:27:24","slug":"inflammatory-bowel-diseases-genomic-medicine-consortium-igenomed","status":"publish","type":"financed-project","link":"https:\/\/genomequebec.com\/en\/funded-projects\/inflammatory-bowel-diseases-genomic-medicine-consortium-igenomed\/","title":{"rendered":"Inflammatory bowel diseases Genomic Medicine Consortium (iGenoMed)"},"content":{"rendered":"

Dawn of a new era for patients with inflammatory bowel diseases as personalized therapeutic approach may soon be here<\/strong><\/p>\n

With its 230,000 reported cases, Canada has one of the world\u2019s highest rates of inflammatory bowel diseases (IBD), such as Crohn\u2019s and ulcerative colitis. A variety of drugs currently exist to treat IBD, but, at the moment, doctors have no way of knowing which drug will work best for which patient. This problem is particularly important given that many new medications are expected to hit the market in the near future.<\/p>\n

Dr. Rioux and his team are working on tests that would enable doctors to match the right drug with the right patient, avoiding the often costly and ineffective trial-and-error approach of selecting a drug. In addition to greatly improving the quality of life of those affected, this tool, once implemented, could help save the health care system several million dollars a year by avoiding costly hospitalizations and surgeries.<\/p>\n

\u00a0<\/p>\n

To learn more about this project, click here<\/a><\/p>\n

\u00a0<\/p>\n

Co-applicants and End-users:<\/strong><\/p>\n\n\n\n<\/colgroup>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Jean<\/td>\nLachaine<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Ramnik<\/td>\nXavier<\/td>\nMass General Hospital (Harvard), USA<\/td>\n<\/tr>\n
Megan<\/td>\nLevings<\/td>\nUniversity of British Columbia<\/td>\n<\/tr>\n
Brian<\/td>\nWhite-Guay<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Denis J.<\/td>\nGarand<\/td>\nUniversit\u00e9 Laval<\/td>\n<\/tr>\n
Sophie\u00a0<\/td>\nVeilleux<\/td>\nUniversit\u00e9 Laval<\/td>\n<\/tr>\n
Christine<\/td>\nDes Rosiers<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Sylvie<\/td>\nLesage<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
Guillaume<\/td>\nLettre<\/td>\nMontr\u00e9al Heart Institute<\/td>\n<\/tr>\n
Mathew<\/td>\nHarding<\/td>\nVertex Pharmaceuticals<\/td>\n<\/tr>\n
Sachdev<\/td>\nSidhu<\/td>\nUniversity of Toronto<\/td>\n<\/tr>\n
Lawrence<\/td>\nJoseph<\/td>\nMcGill University<\/td>\n<\/tr>\n
Lambert<\/td>\nBusque<\/td>\nUniversit\u00e9 de Montr\u00e9al<\/td>\n<\/tr>\n
John<\/td>\nParkinson<\/td>\nVertex Pharmaceuticals<\/td>\n<\/tr>\n
Jos\u00e9e<\/td>\nParent<\/td>\nAssociation des gastro-ent\u00e9rologues du Qu\u00e9bec<\/td>\n<\/tr>\n
Paul<\/td>\nSinclair<\/td>\nCanadian Association of Gastroenterology<\/td>\n<\/tr>\n
Aida<\/td>\nFernande<\/td>\nCrohn\u2019s and Colitis Foundation of Canada<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"featured_media":0,"template":"","class_list":["post-25796","financed-project","type-financed-project","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/financed-project\/25796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/financed-project"}],"about":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/types\/financed-project"}],"wp:attachment":[{"href":"https:\/\/genomequebec.com\/en\/wp-json\/wp\/v2\/media?parent=25796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}